Mr. Sami Adnan Abbasi, DO Dermatology Medicare: Accepting Medicare Assignments Practice Location: 21401 Allen Rd, Woodhaven, MI 48183 Phone: 734-675-0835 Fax: 734-675-0873 |
News Archive
SeraCare Life Sciences, a manufacturer of life sciences tools, bulk plasma, and quality controls for diagnostic companies and clinical laboratories, announced an expansion of its research and manufacturing facilities at its Milford, Massachusetts headquarters.
MonaVie, maker of premier acai-based nutritional and energy drink products, today announces that the lawsuit brought against it and other defendants by Harpo Inc., owner of the Oprah Winfrey family of trademarks, and Dr. Mehmet Oz, a doctor who regularly appeared on The Oprah Winfrey Show and now host of "The Dr. Oz Show," for the unauthorized use of their names and images, has been amicably resolved.
The Abess Center for Ecosystem Science and Policy at the University of Miami today announced it will be honoring Terrence "Rock" Salt, former Principal Deputy Assistant Secretary of the Army, Civil Works, with the 2013 Reitmeister-Abess Center Environmental Stewardship Award.
In a briefing document issued today (28 February) by the Centre for Parenting Culture Studies (CPCS) at the University of Kent, Dr Ellie Lee argues that policy on infant feeding requires a major overhaul if it is to be fit for purpose.
The U.S. Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD). Vonvendi is the first FDA-approved recombinant von Willebrand factor, and is approved for the on-demand (as needed) treatment and control of bleeding episodes in adults diagnosed with VWD.
› Verified 5 days ago